Diaceutics Share News (DXRX)
DXRX Share
DXRX Share
DXRX Share
DXRX Share
DXRX
DXRX Share
DXRX Level 2
DXRX Live
DXRX Broker
DXRX Directors
DXRX Financial
DXRX
DXRX Short
DXRX
Last checked at -
(Sharecast News) - Diaceutics said it had made a "good start" to the 2020 financial year on Tuesday, with trading in the first quarter in line with the board's expectations.
Read more(Sharecast News) - Precision diagnostics commercialisation company Diaceutics announced research results from its Covid-19 oncology tracker on Wednesday, which it said showed the impact of the crisis on cancer testing and diagnosis in the United States.
Read more
Diaceutics Records Profit Fall In 2019 As Expenses Rise
Read more(Sharecast News) - Pharmaceutical data analytics and implementation services provider Diaceutics updated the market on its trading for the year ended 31 December on Monday, reporting that as a result of a strong trading performance in the final quarter, underpinned by an increase in the number of clients and an accelerated growth in product sales, its revenue and adjusted EBITDA for the year were expected to be around £13.4m and above £2.1m, respectively.
Read moreDiaceutics To Exceed 2019 Earnings Guidance, Shares Rise
Read more(Alliance News) - Pharmaceuticals-focused data analytics firm Diaceutics PLC said Monday its maiden interim loss deepened amid listing costs, despite revenue rising a third on the year March, in
Read more(Alliance News) - Diaceutics PLC on Thursday said it has appointed the former general manager of Cloud & Data at Openet to be its new head of Global Data.Derek Hosty will join the data
Read more(Alliance News) - Diaceutics PLC on Monday said it has moved to a net cash position after retiring all outstanding debt from its balance sheet, and is on track for market in the company, which and
Read more(Alliance News) - Diaceutics PLC on Monday said it has invested GBP1 million to expand and enhance its data lake by acquiring another 16 million patient records a year.Diaceutics is a data
Read more(Sharecast News) - Data analytics and implementation services company Diaceutics confirmed the admission of its entire issued ordinary share capital, which comprises 69,583,077 ordinary shares, to trading on AIM on Thursday morning.
Read moreLONDON (Alliance News) - Diaceutics PLC said Thursday its shares have been admitted to trading on AIM after raising GBP17 million as part of its initial public offering.Diaceutics is a data
Read more
Last checked at